fluticasone propionate

Brand: Flovent, Flonase

Prototype Drug
Drug Class: inhaled corticosteroid
Drug Family: corticosteroid
Subclass: glucocorticoid receptor agonist
Organ Systems: respiratoryimmunology

Mechanism of Action

Inhaled synthetic glucocorticoid with high local potency and low systemic bioavailability; binds GR reducing transcription of inflammatory cytokines; suppresses eosinophilic airway inflammation.

glucocorticoid receptor (GR)

Indications

  • asthma maintenance (ICS — first-line)
  • allergic rhinitis (nasal spray)
  • COPD with frequent exacerbations (combined with LABA)

Contraindications

  • active pulmonary infection (TB, fungal)
  • hypersensitivity

Adverse Effects

Common

  • oropharyngeal candidiasis
  • dysphonia
  • HPA axis suppression (high doses)
  • growth suppression in children (high doses)

Serious

  • adrenal crisis (abrupt withdrawal after prolonged use)
  • paradoxical bronchospasm
  • cataracts and glaucoma (long-term high doses)

Pharmacokinetics (ADME)

Absorption inhaled: <1% systemic (extensive first-pass in GI/liver); intranasal: low systemic
Distribution high local tissue binding
Metabolism extensive hepatic CYP3A4 to inactive 17β-carboxylic acid
Excretion fecal ~87%, renal
Half-life ~3-10 hours (inhaled)
Onset minutes (local); hours (anti-inflammatory onset days)
Peak 1-3 hours
Duration 24 hours
Protein Binding 91%
Vd low systemic

Drug Interactions

Drug / Agent Mechanism Severity
strong CYP3A4 inhibitors (ritonavir, itraconazole) systemic fluticasone levels increase — adrenal suppression, Cushing risk major

Nursing Considerations

  1. Rinse mouth and gargle after EVERY use (prevents oral candidiasis and dysphonia)
  2. Anti-inflammatory effect: days to weeks — not for acute bronchospasm
  3. Use lowest effective dose in children to minimize growth suppression
  4. GINA: ICS is cornerstone of asthma management in all but mildest disease
  5. HPA axis suppression with systemic absorption — do not abruptly discontinue after prolonged high-dose use

Clinical Pearls

  • First-line controller for asthma: suppresses eosinophilic inflammation, reduces exacerbations and mortality
  • Oral candidiasis: Candida colonizes with inhaled steroid — spacer and mouth rinse are preventive

Safety Profile

Pregnancy use-with-caution
Lactation use-with-caution
Renal Adjustment Not required
Hepatic Adjustment Not required
TDM Not required
Guideline Update pending

Concordance Terms

Cross-referenced clinical concepts — click any term to see all content where it appears.